MarketersMEDIA / Newsroom / Viscosupplementation Market Is Expected To Grow At An Approximate CAGR Of 5.0% by 2029: Future Market Insights

Viscosupplementation Market Is Expected To Grow At An Approximate CAGR Of 5.0% by 2029: Future Market Insights

Share This Press Release

North America and Europe are the leading regions in the viscosupplementation market owing to the increasing adoption of viscosupplementation products for osteoarthritis and increasing number of clinical trials for the development of viscosupplementation products for different joints.

— The growth of the viscosupplementation market can be attributed to the increasing prevalence of osteoarthritis. According to the latest research by FMI, the global viscosupplementation market is expected to be valued at US$ 3,800 Mn by the end of 2028. The viscosupplementation market is expected to grow with a CAGR of 5.0% during the forecast period 2019-2029. Increase in the population suffering from osteoarthritis is creating high demand for osteoarthritis treatment and pain management drugs, which is expected to result in the robust growth of the viscosupplementation market.

The expanding aging population is a major driving factor driving the viscosupplementation market. Age is an important risk factor for osteoarthritis, and epidemiological studies demonstrate a rise in the prevalence of osteoarthritis with growing age. According to CDC, the prevalence of osteoarthritis was found to be the highest in populations aged between 65 and 75 years. Viscosupplementation emerges as a prior and cost-effective treatment option to delay total knee replacement surgery, which is another major factor propelling the growth of the viscosupplementation market. Cost-analysis studies have shown that viscosupplementation delays the need to perform knee replacement by 2.6 years.

Request a Sample Report with Table of Contents and Figures:

Reimbursement cutbacks are among the major factors that are expected to hamper the growth of the viscosupplementation market. American Association of Orthopedic Surgeons (AAOS) revised the long-standing clinical practice guideline for hyaluronic acid injection in May 2013, after which AAOS cannot recommend hyaluronic acid injection for patients with symptomatic knee osteoarthritis. Due to the AAOS response, most of the reimbursement payers continue deny reimbursements for hyaluronic acid injections. Moreover, the failure of clinical studies and the unavailability of FDA-approved hyaluronic acid injections for joints other than the knees are expected to restrain the growth of the viscosupplementation market.

Market in China to Demonstrate Significant Growth

The global viscosupplementation market has been studied based on the product type and end user. Based on the product type, the viscosupplementation market has been segmented into three-injection viscosupplementation, single-injection viscosupplementation, and five-injection viscosupplementation. The three-injection viscosupplementation segment is expected to hold the maximum market share in the global viscosupplementation market.

Viscosupplementation Market: Combination Therapeutic Products Making a Promising Entry: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029:

Based on end user, the viscosupplementation market has been segmented into hospitals, orthopedic clinics, and ambulatory surgery centers. In terms of revenue, the hospital segment of the viscosupplementation market dominated the global viscosupplementation market in 2018.

North America is expected to dominate the global viscosupplementation market. Although developed countries dominate the market, emerging markets represent higher growth opportunities for the viscosupplementation market. For instance, China is expected to witness the highest growth rate in the viscosupplementation market over the forecast period. Factors, such as rising healthcare facilities and disposable income, are expected to significantly boost the demand for viscosupplementation in the near future.

Buy Full Automotive Door Hinges Market Report Now @

Manufacturers to Strategize on New Product Launches

Manufacturers in the viscosupplementation market follow different strategies to grow their businesses as well as to penetrate the viscosupplementation market. Viscosupplementation market players are focusing on distribution and marketing agreements to enhance their market presence. For example market players such as Anika therapeutic, Bioventus LLC, Seikagaku Corporation, and Zimmer Biomet are focusing on distribution agreements for global market expansion. For instance, DePuy Mitek, Inc. has been distributing Anika Therapeutic’s Orthovisc and Monovisc viscosupplementation products for a long period. In addition, in 2018, Seikagaku Corporation extended its distribution agreement with Bioventus LLC for the distribution of its five injections hyaluronic acid product Supartz FX in the U.S.

Manufacturers are focusing on the launch of new products in the U.S. market. Moreover, they are making efforts to receive approval for their hyaluronic acid-based products for the treatment of other types of joints, apart from the knees, in the U.S. market. Anika Therapeutics, Inc. is focusing on receiving FDA approval for its Cingal, hyaluronic acid, and corticosteroid combination injection.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you:

Some of the key players operating in viscosupplementation market are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Ferring B.V., Seikagaku Corporation, Seikagaku Corporation, Chugai Pharmaceutical Co., Ltd., and Mylan N.V.

More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Venous Thromboembolism Treatment Market: US Remains the Front Runner Driven by Favorable Reimbursement Scenario: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Mucopolysaccharidosis (MPS) Treatment Market: Stem Cell Therapy Research to Prominently Uphold Growth Outlook: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Contact Info:
Name: Abhishek Budholiya
Email: Send Email
Organization: Future Market Insights
Address: 616 Corporate Way, Suite 2-9018,Valley Cottage
Phone: 3479183531

Source URL:

Source: MarketersMedia

Release ID: 88889721

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).